SCHEMBL9713758

SCHEMBL9713758

O=C(Cc1ccccc1)Oc1cc(Sc2ccccc2)c(OC(=O)Cc2ccccc2)c2ccc(Cl)cc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 5/20 0.48
MAPK1 P28482 2/20 0.48
KMT2A Q03164 3/20 0.41
LMNA P02545 3/20 0.41
MEN1 O00255 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
TP53 P04637 1/20 0.40
PDE7A Q13946 1/20 0.38
PDE7B Q9NP56 1/20 0.38
ALOX15 P16050 2/20 0.38
CYP3A4 P08684 1/20 0.38
MAPT P10636 1/20 0.38
TSHR P16473 1/20 0.38
ALOX12 P18054 1/20 0.38
PPARG P37231 1/20 0.38
RECQL P46063 1/20 0.38
BLM P54132 1/20 0.38
HSD17B10 Q99714 1/20 0.38
HPGD P15428 2/20 0.38
ALDH1A1 P00352 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10502745 0.84 L3MBTL1 (0.46) L3MBTL1MAPK1KMT2ALMNAMEN1
SCHEMBL9713703 0.81 ABCB11 (0.51) L3MBTL1MAPK1KMT2ALMNAMEN1
SCHEMBL9713437 0.81 PDE7A (0.40) L3MBTL1MAPK1KMT2ALMNAMEN1
SCHEMBL9713650 0.79 SMN1; SMN2 (0.41) L3MBTL1KMT2ALMNASMN1; SMN2TP53
SCHEMBL30226615 0.79 PDE7A (0.39) L3MBTL1MAPK1KMT2ALMNAMEN1
SCHEMBL9643164 0.75 ABCB11 (0.62) L3MBTL1MAPK1LMNASMN1; SMN2TP53
SCHEMBL30226594 0.75 ABCB11 (0.43) L3MBTL1MAPK1KMT2ALMNAMEN1
SCHEMBL9643180 0.74 CHRM1 (0.49) L3MBTL1KMT2ALMNAMEN1SMN1; SMN2
SCHEMBL9642749 0.71 ABCB11 (0.53) L3MBTL1MAPK1LMNASMN1; SMN2TP53
SCHEMBL9643350 0.70 UCHL1 (0.41) L3MBTL1MAPK1LMNASMN1; SMN2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5091558-A Topical administeration SYNTEX (U.S.A.) INC. (US) 1992-02-25 US disclosed
EP-0150831-B1 NAPHTHALENE ANTI-PSORIATIC AGENTS SYNTEX (U.S.A.) INC. (US) 1988-08-10 EP disclosed
EP-0150831-A2 Naphthalene anti-psoriatic agents SYNTEX (U.S.A.) INC. (US) 1985-08-07 EP disclosed